(*) Doxazosin mesylate (6* mesylate), an important drug of the quinazoline family in current use€ or the treatment of hypertension has also been proven effective for the treatment of benign prostatic hyperplasia (BPH). Doxazosin mesylate displays high binding affinity for a,- adrenoceptor, with no significant activity at q-sites. This mode of action provides appropriate therapy which is being increasingly employed in order to ameliorate hemodynamic ...